Condition

Glioblastoma (1)

Lymphoma (1)

Lymphoma, Large B-Cell, Diffuse (1)

Multiple Myeloma (1)

Pleiotropic Pathway Modifier (1)

Primary Central Nervous System Lymphoma (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Celgene (1)

Collaborator

Intervention

cc-122 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

pleiotropic pathway modifier

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting

Multiple Myeloma
+5 more

CC-122

Duarte, California
+38 more

Aug 18, 2022